About · Team
Clinical & Research Investigators
Investigators who partner with Initio.
Investigators who collaborate with Initio on research and theranostic therapy programs across oncology, nuclear medicine, and precision medicine.
Dr. Kim Chi, MD, FRCPC
Executive Medical Oncologist
About Dr. Kim Chi
Chief Medical Officer, BC Cancer. Lead principal investigator on international Phase III trials for advanced prostate cancer.
Dr. Patrick Martineau, MDCM, PhD, MSc, FRCPC
Theranostics & Nuclear Medicine Specialist
About Dr. Patrick Martineau
Dual-trained clinical researcher and medical physicist. Research focus on personalized treatment planning for radioligand therapies.
Dr. Bernhard Eigl, MD, FRCPC
Precision Oncology & Biomarker Specialist
About Dr. Bernhard Eigl
Provincial Director of Systemic Therapy Clinical Trials at BC Cancer. Pioneer in ctDNA integration into clinical practice.
Dr. Christian Kollmannsberger, MD, FRCPC
Medical Oncologist
About Dr. Christian Kollmannsberger
Chair, BC Cancer Provincial Genitourinary Tumor Group. Internationally recognized expert in testicular and renal cell carcinomas.
Dr. Miles Mannas, MD
Surgeon-Scientist & Urological Oncologist
About Dr. Miles Mannas
Vancouver Prostate Centre. Specializes in robotic urologic oncology with multi-modality imaging–pathology correlation.